Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500095331Phase 4Not yet recruiting
Phase 4, randomised trial of fospropofol disodium in rhinosinusitis (2 arms), sponsored by Dalian Third People's Hospital. Primary endpoint: Changes in hemodynamic indices and BIS values at multiple time points. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500095331.